Ultomiris 300 mg/3mL (Ravulizumab SOLUTION, CONCENTRATE) 300 mg/3mL

Ultomiris 300 mg/3mL is a concentrated solution used for intravenous administration. This medication, containing ravulizumab, is designed to help manage certain medical conditions. Learn more about its uses and effects.

Strength

300 mg/3mL

Pack Size

1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

Alexion Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ultomiris 300 mg/3mL is primarily used for the treatment of specific medical conditions. Ravulizumab, the active ingredient, is often prescribed for conditions related to complement-mediated disorders. Patients may wonder, 'What is Ultomiris used for?' This medication is typically administered intravenously to help manage these conditions.

Side Effects

Common effects of Ultomiris 300 mg/3mL may include reactions at the injection site, such as redness or swelling. Some individuals might experience fatigue or headaches. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Ultomiris 300 mg/3mL should be handled with care, following the instructions provided by a healthcare professional. It is essential to store the medication properly and use it as directed. Patients should inform their healthcare provider about any allergies or other medications they are taking before starting treatment.

Avoid Interactions

Ultomiris 300 mg/3mL may interact with certain medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed, as it may affect the effectiveness of the treatment.

Frequently Asked Questions

Ultomiris is used to manage certain complement-mediated disorders. The specific uses should be discussed with a healthcare provider.

Ultomiris is administered intravenously by a healthcare professional. The dosage and administration schedule will be determined by a healthcare provider.

Common side effects may include injection site reactions, fatigue, and headaches. Any concerns about side effects should be discussed with a healthcare provider.

Ultomiris may interact with certain medications. It is important to discuss all current medications with a healthcare provider before starting treatment.

Ultomiris should be stored according to the instructions provided by the manufacturer. Proper storage is essential to maintain the medication's effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.